Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Opening stock page...
Fetching company snapshot, pricing, and intelligence.
DSGN has basic price and filing data (35% intelligence coverage), but earnings analysis, financial metrics, and proprietary signals are still building. Explore a peer with deeper coverage below.
Intelligence coverage: 35%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 58% · prior close shown (market closed)
Limited proprietary earnings coverage for DSGN yet — signals will sharpen as filings and earnings are ingested.
Pipeline evidence · 33d ago
Reported figures for Design Therapeutics, Inc. — research only, not investment advice.
Updated
What happened recently for Design Therapeutics, Inc. (DSGN) — events, not interpretation.
Research & analysis only — not investment advice.
Investment snapshot
Prior close
$14.83
Market cap
$928.09M
Profitable
No
Net income
$-69.79M
FY Dec 31, 2025
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for Design Therapeutics, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Connected companies and research pages from the AlphaOS knowledge graph.
Follow Design Therapeutics, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.